Charlotte’s Web and DeFloria advance Autism treatment with FDA Phase 2 approval

Pallavi Madhiraju- February 25, 2025 0

Charlotte’s Web Holdings, Inc., a recognized leader in hemp-derived wellness products, has announced a major development in the pursuit of cannabinoid-based medical treatments. DeFloria, Inc., ... Read More

Mirum Pharmaceuticals gains FDA approval for Ctexli, the first drug for CTX

Pallavi Madhiraju- February 23, 2025 0

In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis (CTX), a rare ... Read More

Harmony Biosciences faces FDA setback for pitolisant in idiopathic hypersomnia

Pallavi Madhiraju- February 20, 2025 0

Harmony Biosciences Holdings, Inc. has encountered a regulatory hurdle in its efforts to expand the use of pitolisant for the treatment of excessive daytime sleepiness ... Read More

Clarity Pharmaceuticals bags FDA fast track designation for prostate cancer candidate 67Cu-SAR-bisPSMA

Pallavi Madhiraju- February 19, 2025 0

Clarity Pharmaceuticals has achieved a major regulatory milestone with the United States Food and Drug Administration (FDA) granting Fast Track Designation to 67Cu-SAR-bisPSMA, a targeted ... Read More

FDA grants Breakthrough Therapy Designation to Lacutamab for Sézary Syndrome

Pallavi Madhiraju- February 17, 2025 0

Innate Pharma has achieved a significant regulatory milestone with the U.S. Food and Drug Administration (FDA) granting Breakthrough Therapy Designation for lacutamab, a first-in-class anti-KIR3DL2 ... Read More

Axsome Therapeutics wins big in Auvelity patent battle, stock jumps 14%

Pallavi Madhiraju- February 10, 2025 0

Axsome Therapeutics Inc. experienced a sharp rise in its share price, climbing 14% in premarket trading following the announcement of a settlement agreement with Teva ... Read More

FDA approves EMBLAVEO to combat complicated intra-abdominal infections with limited treatment options

Pallavi Madhiraju- February 9, 2025 0

The U.S. Food and Drug Administration (FDA) has granted approval for EMBLAVEO (aztreonam and avibactam), marking a significant milestone in the fight against complicated intra-abdominal ... Read More

Lipella Pharmaceuticals secures FDA approval for expanded access program for LP-310 in oral lichen planus

Pallavi Madhiraju- February 6, 2025 0

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company dedicated to addressing unmet medical needs, has announced that it has received approval from the U.S. Food and ... Read More

Vaxart’s oral COVID-19 vaccine gains momentum with DSMB approval

Pallavi Madhiraju- January 14, 2025 0

Vaxart, Inc., a clinical-stage biotechnology company headquartered in South San Francisco, has announced a critical advancement in its innovative oral COVID-19 vaccine candidate. An independent ... Read More

Boston Scientific to expand cardiovascular portfolio with Bolt Medical acquisition

Pallavi Madhiraju- January 8, 2025 0

Boston Scientific Corporation has announced a definitive agreement to acquire Bolt Medical, Inc., a developer of cutting-edge intravascular lithotripsy (IVL) technology. The acquisition reflects Boston ... Read More

123420 / 38 Posts